Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.

ABSTRACT: In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H?N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H?O hydrogen bonds. C-H?? and ?-? inter-actions are also present; in the latter, the centroid-centroid distances are 4.075?(1) and 3.719?(1)?Å.

SUBMITTER: Akonan L

PROVIDER: S-EPMC2979779 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.

Akonan Ludovic L Molou Kouassi Yves Guillaume KY Adohi-Krou Adjo A Abou Akoun A Tenon Abodou Jules AJ

Acta crystallographica. Section E, Structure reports online 20100123 Pt 2

In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å. ...[more]

PMID: 21579857

Similar Datasets

Bis{2-[4-(methyl-sulfan-yl)phen-yl]-1H-benzimidazol-3-ium} tetra-bromido-cadmate(II) ethanol monosolvate.

Project description:In the anion of the title compound, (C(14)H(13)N(2)S)(2)[CdBr(4)]·C(2)H(5)OH, the Cd(II) atom is in a distorted tetra-hedral environment and one of the Br atoms is disordered over three sites with site-occupancy factors of 0.828?(5), 0.106?(3) and 0.068?(4). In the crystal, inter-molecular N-H?O, C-H?O and N-H?Br inter-actions result in a two-dimensional polymeric network extending parallel to (010).

| S-EPMC3120599 | biostudies-literature

Bis{2-[4-(methyl-sulfan-yl)phen-yl]-1H-benzimidazol-3-ium} tetra-bromido-cuprate(II) dihydrate.

Project description:The asymmetric unit of the title compound, (C(14)H(13)N(2)S)(2)[CuBr(4)]·2H(2)O, contains two cations, one anion and two solvent water mol-ecules that are connected via O-H?Br, N-H?Br and N-H?O hydrogen bonds into a two-dimensional polymeric structure. The cations are arranged in a head-to-tail fashion and form stacks along [100]. The central Cu(II) atom of the anion is in a distorted tetra-hedral environment.

| S-EPMC3089137 | biostudies-literature

2-[(1H-Benzimidazol-2-yl)sulfan-yl]-1-phenyl-ethanone.

Project description:The title compound, C(15)H(12)N(2)OS, adopts a twisted V-shape, with the S atom as the pivot. The benzimidazole ring system [maximum deviation = 0.015 (1) Å] makes a dihedral angle of 78.56 (7)° with the phenyl ring. The O atom of the ketone group is close to coplanar with its adjacent ring [O-C-C-C torsion angle = 11.0 (2)°]. In the crystal, mol-ecules are linked by N-H⋯N hydrogen bonds into an infinite chain along [001]. The crystal packing also features a C-H⋯π inter-action.

| S-EPMC3394045 | biostudies-literature

1-Methyl-4-({5-[(4-methyl-phen-yl)sulfan-yl]pent-yl}sulfan-yl)benzene.

Project description:There are two independent mol-ecules in the asymmetric unit of the title compound, C(19)H(24)S(2). In both mol-ecules, the aliphatic segment of the ligand is in an all-trans conformation: the -S-(CH(2))(5)-S-bridging chain is almost planar (r.m.s. deviation for all non-H atoms = 0.0393 and 0.0796?Å in the two mol-ecules) and maximally extended. Their mean planes form dihedral angles of 4.08?(6)/20.47?(6) and 2.22?(6)/58.19?(6)° with the aromatic rings in the two mol-ecules. The crystal packing is purely governed by weak inter-molecular forces.

| S-EPMC2972162 | biostudies-literature

(±)-1-(1H-Benzimidazol-2-yl)ethanol.

Project description:The asymmetric unit of the title mol-ecule, C(9)H(10)N(2)O, contains two mol-ecules. The fused benzene and imidazole rings are nearly coplanar, the largest deviations from the mean plane being 0.025 (3) Å at the non-bridgehead imidazole C atom of one mol-ecule and 0.018 (3) Å at one of the bridgehead C atoms in the other mol-ecule. Intermolecular O-H⋯N and N-H⋯O hydrogen bonds result in the formation of a sheet parallel to the (010) plane.

| S-EPMC2961813 | biostudies-literature

4,6-Bis[4-(benzyl-sulfan-yl)styr-yl]-2-(methyl-sulfan-yl)pyrimidine.

Project description:The title compound, C(35)H(30)N(2)S(3), has been synthesized by a solvent-free reaction. The mol-ecule exhibits an E,E configuration, the benzene rings and pyrimidine rings being located on the opposite sides of the C=C bonds. The centroid-centroid separation of 3.5808 (17) Å indicates the existence of π-π stacking between nearly parallel pyrimidine and benzene rings of adjacent mol-ecules.

| S-EPMC2915314 | biostudies-literature

Bis[(methyl-sulfan-yl)carbon-yl]disulfane.

Project description:The title compound, C(4)H(6)O(2)S(4), was prepared by repeating, with subtle improvements, a multi-step route originally described by Mott & Barany [J. Chem. Soc. Perkin Trans. 1 (1984) ▶, pp. 2615-2621]. The title compound was obtained for the first time as a crystalline material. The two [(methyl-sulfan-yl)carbon-yl]sulfenyl moieties are essentially perpendic-ular to each other, each approximately planar (r.m.s. deviations of 0.02 and 0.01 Å) and with a C-S-S-C torsion angle = 90.99 (6)°, which compares well with the theoretical value of 90°.

| S-EPMC3393915 | biostudies-literature

N-[(Methyl-sulfan-yl)meth-yl]benzamide.

Project description:In the title compound, C(9)H(11)NOS, the phenyl ring and formamide unit make a dihedral angle of 23.93 (14)°, whereas the (methyl-sulfan-yl)methyl group is oriented at a dihedral angle of 61.31 (8)° with respect to the phenyl ring. There are inter-molecular N-H⋯O hydrogen bonds, forming C(4) chains along the [010] direction. These polymeric chains are linked by C-H⋯O hydrogen bonds to form polymeric sheets in the (110) plane.

| S-EPMC3295445 | biostudies-literature

2-Methyl-6-(6-methyl-1H-benzimidazol-2-yl)phenol-2-methyl-6-(5-methyl-1H-benzimidazol-2-yl)phenol (3/1).

Project description:The title compound, 0.75C(15)H(14)N(2)O·0.25C(15)H(14)N(2)O, is a co-crystal of 2-methyl-6-(6-methyl-1H-benzimidazol-2-yl)phenol as the major component and 2-methyl-6-(5-methyl-1H-benz-imidazol-2-yl)phenol as the minor component. The refined site-occupancy ratio is 0.746?(4)/0.254?(4). The conformations of both components are identical except for that of the methyl substituent on the benzene ring of the benzimidazole unit which is positionally disordered over two positions. The mol-ecule is essentially planar, the dihedral angle between the benzimidazole plane and the benzene ring being 3.49?(4)°. An intra-molecular O-H?N hydrogen bond generates an S(6) ring motif. In the crystal packing, mol-ecules are linked through N-H?O hydrogen bonds into chains along [201]. These chains are stacked approximately along the a-axis direction. The crystal packing is further stabilized by weak N-H?O and O?H?N hydrogen bonds, together with weak inter-molecular C-H?? inter-actions. A ?-? inter-action with a centroid-centroid distance of 3.6241?(6)?Å is also observed between the substituted phenyl ring and that of the benzimidazole system.

| S-EPMC2972110 | biostudies-literature

Tris[4-(methyl-sulfan-yl)phen-yl]arsine.

Project description:In the title compound, C(21)H(21)AsS(3), the three benzene rings make dihedral angles of 88.41?(10), 87.75?(9) and 74.74?(10)° with each other. The methyl-sulfanyl groups are roughly coplanar with their attached benzene rings [C-S-C-C torsion angles = -7.6?(2), 11.2?(2) and 4.1?(2)°]. In the crystal, weak C-H?? inter-actions link the mol-ecules.

| S-EPMC3007364 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data